Zinc Monomethionine (OptiZinc).
Zinc bound to methionine for enhanced absorption and antioxidant benefits. Zinc held as a neutral chelate by methionine. It feeds the several hundred zinc enzymes and zinc-finger proteins you run on, and it resists phytate in the gut.
Reviewed March 2026
- Category
- Mineral
- Also filed under
- AbsorptionAntioxidantAthletic performance
What Zinc Monomethionine (OptiZinc) is, and what it does.
- Does it work
- Suits people eating a lot of whole grains and legumes, where phytate ties zinc up. Also suits anyone who finds plain zinc salts hard on the stomach.
- How much to take
- Start with 8mg to 25mg of elemental zinc a day, with a meal. Read the elemental figure on the label rather than the compound weight.
- Time to feel it
- Blood zinc responds within days. The parts you would notice, skin behaviour and immune resilience, take four to twelve weeks of steady intake.
- The first dose
- Quiet, as long as you take it with food. On an empty stomach any zinc, chelated or not, can turn the stomach.
- With regular use
- Weeks of daily use bring zinc status up and hold it there. It shows on a blood panel first and in skin and immune resilience later.
- How well tolerated
- Well tolerated at everyday amounts taken with food. Sustained intake above roughly 40mg a day lowers copper absorption, so long runs want copper alongside.
- How it feels
- No lift and no sedation. It runs in the background; what changes across months is how often you get run down and how your skin behaves.
- The overlooked benefit
- Methionine is a sulfur amino acid, so the ligand here is a nutrient in its own right rather than an inert counterion that gets discarded.
8 to 15mg a day is where Zinc Monomethionine (OptiZinc) works.
Source: NIH ODS + Prasad 2008 zinc review
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
Zinc Monomethionine (OptiZinc) has emerging evidence. Based on 25+ studies.
- normal immune system functionMeta-analysis
- zinc absorption in the presence of dietary phytateRandomised trial
- normal skin, hair and nail maintenanceNarrative review
- testosterone already in the normal rangeRandomised trial
- copper status at sustained high zinc intakeRandomised trial
Questions people ask about Zinc Monomethionine (OptiZinc).
- Is this better than zinc picolinate?
- Both absorb well. Monomethionine may be slightly gentler on the stomach. Either is a good choice.
- Do I need to take copper with this?
- If taking over 30mg zinc daily for extended periods, yes. Zinc can deplete copper over time.
- Can I take this for acne?
- Yes. Zinc helps with acne. 30mg daily for 2-3 months is a common approach. Results vary.
- Will this help my immune system?
- If you're deficient, absolutely. Zinc is critical for immune function. If you're already sufficient, extra won't help much.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Zinc monomethionine is absorbed well and induces intestinal metallothionein, which binds copper and lowers copper status on sustained use. Products in this form are conventionally sold with a small copper amount for that reason.
Methionine and cysteine are the two sulfur amino acids that coordinate zinc, and methionine converts to cysteine through transsulfuration. The ligand chemistry that makes this form absorbable is the same chemistry cysteine supplies.
Histidine and methionine both hold zinc as small soluble complexes that resist precipitation at duodenal pH. They are alternative carriers of the same ion.
Amino acid chelation reduces but does not remove competition with non-heme iron for divalent uptake. Dosing the two together still lowers both.
Phytate binds zinc more strongly than a single amino acid ligand does, so a phytate-rich meal pulls zinc off the methionine complex. Phytase cleaves the phytate and leaves the chelate intact.
High calcium in the same dose reduces fractional zinc absorption by competing for divalent uptake. Separating the two preserves both minerals.
Retinol-binding protein synthesis and the retinol dehydrogenase step both need zinc, so vitamin A availability follows zinc status. The relationship is a direct dependency.
Zinc-dependent superoxide dismutase produces the peroxide that selenium-dependent glutathione peroxidase clears. Both minerals are needed to complete the sequence.
The methionine carrier of this form enters the methionine cycle, and TMG donates a methyl group that regenerates methionine from homocysteine. The two intersect on the same one-carbon pathway, though the methionine load from a zinc chelate is small.
Cystathionine beta-synthase and cystathionine gamma-lyase, the enzymes that carry methionine sulfur onward to cysteine, are both B6 dependent. B6 handles the fate of the ligand while zinc is the mineral it delivered.
Methionine is the ligand in this complex, coordinating zinc through its amino and carboxyl groups. The neutral amino acid chelate keeps zinc from being bound by phytate and other luminal anions and lets it travel with amino acid handling rather than as a free cation. This is the defining chemistry of the ingredient.
Zinc and manganese are both divalent transition metals absorbed across the enterocyte with overlapping transporter use, notably DMT1. A high zinc load reduces manganese uptake from the same meal, and the same is true in the other direction. Multimineral formulas balance the two for this reason.
Non-haem iron and zinc compete at DMT1 in the duodenum, and the competition is most pronounced when both are taken as a large dose in water without food. Separating the two doses by a few hours is the standard formulation answer. The competition is at the absorption step and does not affect either mineral once absorbed.
Amino acid chelated iron is described as being less subject to luminal inhibitors than a simple salt, but zinc and iron still overlap in enterocyte handling. Competition between the two is reduced compared with sulfate rather than eliminated. Read the difference as a matter of degree, not a separate pathway.
Large calcium doses lower zinc absorption from the same meal, an effect that grows with the calcium load and with phytate present. Carbonate also raises gastric pH, which reduces the dissolution of zinc from less soluble salts. An amino acid chelate is less pH dependent than an oxide, though the calcium effect still applies.
Tannins and other polyphenols carry adjacent hydroxyl groups that chelate divalent metals in the gut lumen and form poorly absorbed complexes. Tea and coffee taken with a mineral dose reduce uptake through this mechanism. Amino acid chelation offers some protection because the zinc is already coordinated.
Pectin carries free carboxyl groups along its galacturonic acid backbone that bind divalent cations including zinc. Some of that bound mineral is released again when colonic bacteria ferment the pectin. The net effect on absorption depends on where the fibre is fermented, so the direction is not fixed.
A viscous soluble fibre gel slows diffusion of dissolved minerals toward the mucosal surface and provides binding sites within the matrix. Taking a mineral dose in the same glass as a bulking fibre is generally avoided for that reason. The magnitude for a chelated zinc is not established.
Smectite clays carry a permanent negative layer charge and exchange cations with the surrounding fluid, which is the basis of their binding capacity. Zinc is a divalent cation and is among the species exchanged. Spacing a mineral dose away from a clay product follows directly from the ion-exchange chemistry.
Activated carbon adsorbs a broad range of luminal species onto its high-surface-area pores, and it is non-selective. A mineral supplement taken at the same time may be adsorbed along with everything else. Timing separation is the usual formulation instruction.
Colonic fermentation of inulin produces short-chain fatty acids that lower luminal pH and keep divalent minerals in solution where some colonic absorption can occur. The pH mechanism is well described for calcium and has been extended to zinc. Whether it changes zinc status in a person is not established.
GOS is fermented in the proximal colon, generating short-chain fatty acids that acidify the lumen and increase the soluble fraction of divalent minerals. The mineral-solubility effect follows from the pH change. Direct measurement of a zinc effect from GOS is limited.
Like other fermentable oligosaccharides, FOS lowers colonic pH through short-chain fatty acid production, which keeps more of any remaining zinc in a soluble form. This is a solubility mechanism rather than a transporter effect. The evidence base is stronger for calcium than for zinc.
Resistant starch escapes small intestinal digestion and is fermented distally, producing butyrate and lowering luminal pH. The same solubility argument made for other fermentable substrates applies. Direct zinc data are thin, so read this as mechanistic.
Dietary protein raises zinc absorption, partly because digestion releases amino acids and peptides that keep zinc soluble and coordinated in the lumen. Cysteine and histidine-containing peptides are the most effective ligands. This is the same principle the methionine chelate is built on.
Casein phosphopeptides bind divalent cations including zinc, and the effect can either hold zinc in solution or sequester it depending on the calcium load in the same meal. The binding chemistry is described; the net direction for zinc uptake is not settled. Ratio matters more than presence.
Zinc binds to cysteine thiols, and glutathione is the dominant intracellular thiol pool that buffers labile zinc alongside metallothionein. Zinc in turn stabilises the enzymes of thiol redox handling. The two are linked through cellular thiol chemistry rather than through absorption.
N-acetylcysteine carries a free thiol that coordinates divalent metals including zinc, so it can bind zinc in the lumen and also feeds cysteine into the intracellular thiol pool. The direction depends on where the interaction happens. Read it as a coordination chemistry note rather than an absorption claim.
Dihydrolipoic acid has two thiol groups and binds divalent transition metals, which is the basis of the metal-binding behaviour attributed to lipoic acid. Whether that shifts zinc distribution meaningfully at supplement doses is not established. The binding itself is documented in laboratory systems.
Quercetin chelates divalent metals at its catechol and 3-hydroxy-4-keto sites, forming zinc complexes that have been characterised in vitro. Formulators have used this to alter zinc distribution across membranes. What it does to zinc status after an oral dose has not been measured.
Carnosine is a beta-alanyl-histidine dipeptide whose imidazole nitrogen coordinates zinc, which is the basis of the separate zinc-carnosine complex used in gastric formulations. The coordination chemistry is the same principle as the methionine complex with a different ligand. Ligand choice changes solubility and tissue behaviour rather than the elemental zinc delivered.
The vitamin D receptor is a zinc finger protein and cannot bind DNA without its structural zinc ions. Vitamin D signalling therefore depends on adequate zinc regardless of vitamin D status. The structural requirement is settled; whether supplementing both together changes anything measurable is not.
Some lactic acid bacteria lower intestinal pH and hydrolyse phytate, both of which raise the soluble mineral fraction in the lumen. This is a plausible route to better zinc availability from a mixed meal. Direct human measurement for zinc is limited, so keep the claim mechanistic.
Both are divalent cations and a very large dose of one can reduce the absorbed fraction of the other from the same serving, though the effect is smaller than the zinc and iron or zinc and copper interactions. At ordinary multimineral levels the interference is modest. Splitting large single-mineral doses is the practical answer.
Nothing specific on file for Zinc Monomethionine (OptiZinc). Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.What Zinc Monomethionine (OptiZinc) actually does.
Zinc monomethionine is a coordination complex in which zinc is bound by the amino nitrogen and carboxylate oxygen of L-methionine, giving a neutral chelate rather than an ionic salt.
Zinc is a catalytic or structural component of hundreds of human enzymes, including carbonic anhydrase, alcohol dehydrogenase, alkaline phosphatase, the matrix metalloproteinases and cytosolic superoxide dismutase, where it pairs with copper.
Zinc finger domains use zinc ions to hold a fold that binds DNA, and this structural role underlies a large fraction of human transcription factor activity.
Zinc entry and exit from cells is handled by the ZIP and ZnT transporter families, and intracellular free zinc is buffered by metallothionein.
Where Zinc Monomethionine (OptiZinc) comes from.
Two starting materials are combined in water: a simple zinc salt made from mined zinc, and the amino acid methionine. Under the right acidity they lock together into a single neutral molecule, which is then washed, tested for how much zinc it actually contains, dried and milled into powder. The impurity testing matters because zinc ore naturally sits alongside heavier metals.
The same molecule is reached more than one way. Which route a given product used is a manufacturing choice, and the finished compound is the same either way.
A soluble zinc source such as zinc sulfate or zinc oxide, and L-methionine produced by chemical synthesis with enzymatic resolution or by fermentation.
Zinc and methionine are combined in aqueous solution at a controlled one-to-one molar ratio and a pH that favours coordination through the amino nitrogen and the carboxylate oxygen.
The complex is separated from unreacted starting material and residual counter-ions, with soluble sulfate or chloride washed out.
Zinc content is confirmed by atomic absorption or ICP, and heavy metal limits including cadmium and lead are checked against the ingredient specification.
The chelate is dried to low moisture and milled to a flowable powder for tabletting or encapsulation.
Getting Zinc Monomethionine (OptiZinc) from food.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
Zinc Monomethionine (OptiZinc) is a form of Zinc.
Zinc Monomethionine (OptiZinc) is the monomethionine form of Zinc. Same mineral, bound to a different partner, so absorption and feel differ from form to form.
The essence, in one line each.
- Pooling three randomized trials, zinc acetate lozenges shortened the duration of common cold symptoms by about 2.7 days against a roughly seven-day average.Meta-analysis. Hemilä et al., 2016 (British Journal of Clinical Pharmacology). PMID 27378206 ↗
- In children older than six months, zinc supplementation may shorten the average duration of acute diarrhea by about half a day, a mean difference of roughly 11 hours across nine trials, on low certainty evidence.Systematic review and meta-analysis. Lazzerini and Wanzira, 2016 (Cochrane Database of Systematic Reviews). PMID 27996088 ↗
- Across 36 studies in children under five, zinc supplementation modestly increased linear growth; in the studies reporting absolute change, about 10 mg a day for 24 weeks added roughly 0.37 cm in height versus placebo.Meta-analysis. Imdad and Bhutta, 2011 (BMC Public Health). PMID 21501440 ↗
- Pooling randomised trials in adults, zinc had a small effect on body weight and waist circumference and no detectable effect on body mass index, fat mass, fat-free mass or adipokine levels, and the authors call the size of the changes minor.Meta-analysis. Salmani et al., 2026 (Biological Trace Element Research). PMID 41617950 ↗
- Across four trials in women of reproductive age, zinc lowered reported total premenstrual symptom scores (Hedges g -0.38) and emotional symptom scores (g -0.35) at moderate certainty, with physical symptoms (g -0.51) resting on low certainty.Meta-analysis. Kim et al., 2025 (Women and Health). PMID 40737185 ↗
- Across six trials with 739 women, zinc lowered reported menstrual discomfort scores (Hedges g -1.54), with larger reductions when taken for eight weeks or longer and an effect seen at doses as low as 7 mg of elemental zinc a day.Meta-analysis. Hsu et al., 2024 (Nutrients). PMID 39683510 ↗
- Across 77 trials, zinc on its own during healthy pregnancy raised maternal serum zinc (SMD 0.32 second trimester, 0.51 third), cord blood zinc and one-minute Apgar scores, and was linked to greater birth length and head circumference, while zinc with iron and folate added nothing over iron and folate alone.Meta-analysis. Diao et al., 2025 (Journal of Evidence-Based Medicine). PMID 40836314 ↗
- Pooling randomised trials in young women, zinc supplementation was associated with milder self-reported physical and mood-related symptoms around the menstrual cycle.Meta-analysis. Haider et al., 2025 (European journal of obstetrics, gynecology, and reproductive biology). PMID 40435711 ↗
- In Tanzanian infants, daily zinc supplementation shifted circulating metabolomic markers, showing that supplemental zinc reaches and alters measurable metabolism.Randomised trial. Liu et al., 2024 (The Journal of nutrition). PMID 38092153 ↗
- Pooling trials in adults with long-standing liver impairment, the reviewers reported changes in biochemical measures including serum zinc and blood ammonia with supplementation; those are laboratory markers, and clinical endpoints were reported less consistently.Meta-analysis. Gong Y et al., 2026 (BMC Nutrition). PMID 41527112 ↗
- Serum zinc concentration below a defined threshold was associated with worse recorded outcomes in this observational cohort; an association in a cohort is not evidence that low zinc caused the difference.Cohort study. Tanaka Y et al., 2026 (Nutrients). PMID 42124080 ↗
- A systematic review of how consistently caregivers gave the full recommended oral zinc course to children under five with acute loose stools; the endpoint is adherence to the regimen, not whether zinc changed the illness.Systematic review. Pradhan SK et al., 2025 (Epidemiology and Infection). PMID 41178278 ↗
- A secondary analysis of a randomised zinc trial identifying factors associated with vomiting during an episode of loose stools; these are associations found within trial data, not effects the randomisation was designed to test.Randomised trial. Edwards JG et al., 2025 (Journal of Pediatric Gastroenterology and Nutrition). PMID 39806793 ↗
- A placebo-controlled randomised trial measuring circulating inflammatory markers and markers of gut barrier integrity after zinc supplementation; all primary readouts are blood markers rather than clinical events.Randomised trial. Baissary J et al., 2025 (Nutrients). PMID 40431411 ↗
- An open-label randomised comparison measuring body fat mass after zinc supplementation in adults on maintenance dialysis; open-label design leaves expectation effects on body composition measures unaddressed.Open-label trial. Fukasawa H et al., 2025 (Therapeutic Apheresis and Dialysis). PMID 39400501 ↗
- Oral zinc was tested against control using bioelectrical impedance phase angle and vector analysis as the endpoints in boys with a genetic muscle-wasting condition; phase angle is a body-composition marker, not a functional outcome.Randomised trial. Vermeulen-Serpa KM et al., 2024 (Nutrients). PMID 39408270 ↗
- A randomised controlled trial of zinc supplementation in very low birth weight infants reporting growth and biochemical measures during the neonatal stay.Randomised trial. Sahin S et al., 2024 (American Journal of Perinatology). PMID 37939725 ↗
- Serum zinc concentrations were measured after supplementation in very low birth weight infants; serum zinc is a status marker and moves with supplementation, which does not by itself describe a clinical effect.Randomised trial. Hiruta S et al., 2026 (Nutrition). PMID 42314307 ↗
- A systematic review and pooled analysis of newborn trials that gave zinc and measured bilirubin concentrations and the need for phototherapy; the included trials were small and varied in dose and timing.Systematic review. Chitiki GDR et al., 2026 (Journal of Neonatal-Perinatal Medicine). PMID 41994906 ↗
- The published protocol for a randomised trial of zinc in young infants with severe clinical illness in Tanzania, setting out dose and endpoints; it reports no results.Randomised trial. Manji KP et al., 2025 (BMJ Paediatrics Open). PMID 40813142 ↗
- A combined intervention of a teach-back education model plus zinc supplementation was compared against usual care in children, with symptom scores and immune markers reported; because two components were given together, the contribution of zinc alone cannot be separated.Randomised trial. Qin Y et al., 2025 (African Journal of Reproductive Health). PMID 40387134 ↗
- A single case describing neurological signs alongside low copper status in a person taking large amounts of supplemental zinc over an extended period, consistent with the known effect of high zinc intake on copper absorption; a single case cannot establish how often this occurs.Case report. Silva MTT et al., 2026 (Practical Neurology). PMID 40866286 ↗
- A systematic review of zinc supplementation in lambs reporting growth performance, mineral metabolism and nutrient digestibility; findings are in a ruminant animal model and do not transfer to human dosing.Animal study. Darabi M et al., 2026 (Biological Trace Element Research). PMID 40634832 ↗
These are the studies our verdict leans on, chosen from the 8,967 we read for Zinc Monomethionine (OptiZinc). The full linked list is below.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.